Compare PARR & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PARR | AXGN |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2000 | 2013 |
| Metric | PARR | AXGN |
|---|---|---|
| Price | $60.99 | $31.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $50.60 | $37.63 |
| AVG Volume (30 Days) | ★ 1.4M | 813.8K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1313.56 | N/A |
| EPS | ★ 7.16 | N/A |
| Revenue | ★ $2,443,066,000.00 | $225,208,000.00 |
| Revenue This Year | N/A | $19.81 |
| Revenue Next Year | $4.98 | $16.31 |
| P/E Ratio | $8.09 | ★ N/A |
| Revenue Growth | ★ 30.99 | 20.21 |
| 52 Week Low | $12.04 | $9.22 |
| 52 Week High | $60.13 | $36.00 |
| Indicator | PARR | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 80.07 | 46.30 |
| Support Level | $34.55 | $30.42 |
| Resistance Level | N/A | $34.26 |
| Average True Range (ATR) | 2.84 | 1.45 |
| MACD | 1.00 | 0.11 |
| Stochastic Oscillator | 96.42 | 52.82 |
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.